Literature DB >> 19646969

The combined therapy of intrahippocampal transplantation of adult neural stem cells and intraventricular erythropoietin-infusion ameliorates spontaneous recurrent seizures by suppression of abnormal mossy fiber sprouting.

Meng Jing1, Tetsuro Shingo, Takao Yasuhara, Akihiko Kondo, Takamasa Morimoto, Feifei Wang, Tanefumi Baba, Wen Ji Yuan, Naoki Tajiri, Takashi Uozumi, Mayu Murakami, Mariko Tanabe, Yasuyuki Miyoshi, Shiguang Zhao, Isao Date.   

Abstract

Adult neural stem cells (NSCs) possess the potentials to self-renew and exert neuroprotection. In this study, we examined whether adult NSCs had anti-epileptic effects in rats with status epilepticus (SE) induced by kainic acid (KA) and whether co-administration of erythropoietin (EPO) enhanced anti-epileptic effects or cell survival. Adult NSCs were transplanted into KA-lesioned hippocampus with or without intracerebroventricular EPO infusion. Electronic encephalography (EEG) was recorded for 3 weeks after transplantation. The frequency of abnormal spikes in rats with NSC transplantation decreased significantly compared to those of rats without NSC transplantation. Most of the transplanted NSCs differentiated into GFAP-positive astrocytes. EPO infusion significantly enhanced the survival of NSCs, but not neuronal differentiation or migration. NSC transplantation increased the number of neuropeptide Y (NPY) and glutamic acid decarboxylase 67 (GAD67)-positive interneurons. NSC transplantation also suppressed mossy fiber sprouting into the inner molecular layer with subsequent reduction of hippocampal excitability, which finally prevented the development of spontaneous recurrent seizures in adult rats after KA-induced SE. This study might shed light on the cytoarchitectural mechanisms of temporal lobe epilepsy as well as clarify the effect of adult NSC transplantation with intracerebroventricular EPO infusion for temporal lobe epilepsy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19646969     DOI: 10.1016/j.brainres.2009.07.079

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  17 in total

1.  Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy.

Authors:  Ben Waldau; Bharathi Hattiangady; Ramkumar Kuruba; Ashok K Shetty
Journal:  Stem Cells       Date:  2010-07       Impact factor: 6.277

2.  Rassmussen's encephalitis: are there new, better therapeutic medical and surgical guidelines?

Authors:  Svetlana Gataullina; Olivier Dulac
Journal:  Epilepsia       Date:  2010-02       Impact factor: 5.864

3.  Cell Therapy From Bench to Bedside Translation in CNS Neurorestoratology Era.

Authors:  Hongyun Huang; Lin Chen; Paul Sanberg
Journal:  Cell Med       Date:  2010-01-01

Review 4.  Recent advancements in stem cell and gene therapies for neurological disorders and intractable epilepsy.

Authors:  Janice R Naegele; Xu Maisano; Jia Yang; Sara Royston; Efrain Ribeiro
Journal:  Neuropharmacology       Date:  2010-02-08       Impact factor: 5.250

5.  Cyclohexane Inhalation Produces Long-Lasting Alterations in the Hippocampal Integrity and Reward-Seeking Behavior in the Adult Mouse.

Authors:  Tania Campos-Ordonez; David Zarate-Lopez; Nereida Ibarra-Castaneda; Jonathan Buritica; Oscar Gonzalez-Perez
Journal:  Cell Mol Neurobiol       Date:  2019-02-15       Impact factor: 5.046

Review 6.  Novel therapeutic approaches for disease-modification of epileptogenesis for curing epilepsy.

Authors:  Bryan L Clossen; Doodipala Samba Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-02-05       Impact factor: 5.187

Review 7.  Progress in cell grafting therapy for temporal lobe epilepsy.

Authors:  Ashok K Shetty
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 8.  A Molecular Approach to Epilepsy Management: from Current Therapeutic Methods to Preconditioning Efforts.

Authors:  Elham Amini; Mohsen Rezaei; Norlinah Mohamed Ibrahim; Mojtaba Golpich; Rasoul Ghasemi; Zahurin Mohamed; Azman Ali Raymond; Leila Dargahi; Abolhassan Ahmadiani
Journal:  Mol Neurobiol       Date:  2014-09-09       Impact factor: 5.590

9.  Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trial.

Authors:  Kyunghoon Min; Junyoung Song; Jin Young Kang; Jooyeon Ko; Ju Seok Ryu; Myung Seo Kang; Su Jin Jang; Sang Heum Kim; Doyeun Oh; Moon Kyu Kim; Sung Soo Kim; Minyoung Kim
Journal:  Stem Cells       Date:  2013-03       Impact factor: 6.277

Review 10.  Regenerative medicine for epilepsy: from basic research to clinical application.

Authors:  Takao Yasuhara; Takashi Agari; Masahiro Kameda; Akihiko Kondo; Satoshi Kuramoto; Meng Jing; Tatsuya Sasaki; Atsuhiko Toyoshima; Susumu Sasada; Kenichiro Sato; Aiko Shinko; Takaaki Wakamori; Yu Okuma; Yasuyuki Miyoshi; Naoki Tajiri; Cesario V Borlongan; Isao Date
Journal:  Int J Mol Sci       Date:  2013-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.